
Immune networks in tumors prime responses to a personalized immunotherapy
FEBRUARY 2, 2024, NEW YORK – Through an analysis of tumor samples collected over time from patients with advanced melanoma, a Ludwig Cancer Research study has identified a set of preexisting conditions in tumors that predict whether such patients are likely to respond to a personalized